Whole Virion, Inactivated Corona Virus vaccine

Uses

Whole Virion Inactivated Coronavirus Vaccine The Whole Virion Inactivated Coronavirus Vaccine is used to prevent Coronavirus disease (COVID-19).

How it Works

How Whole Virion Inactivated Coronavirus Vaccine Works The Whole Virion Inactivated Coronavirus vaccine contains an inactivated form of the virus itself, composed of killed coronaviruses, making it safe for injection into the body. When administered, the dead virus acts as an antigen and provokes an immune response that can block or eliminate the virus without causing the disease. Thus, the Whole Virion Inactivated Coronavirus vaccine is incapable of infecting individuals but can instruct the immune system to mount a defensive reaction if a person becomes infected, similar to the natural immune response seen with other infections, such as the common cold or flu.

Side Effects

Common side effects of the Whole Virion Inactivated Corona Virus vaccine include injection site reactions (such as pain, swelling, and redness), headache, fever, discomfort, nausea, vomiting, and rash.

Expert Advice

  • Two doses of the Whole Virion, Inactivated Corona Virus vaccine are administered 4 to 6 weeks apart.
  • Ensure that you complete the dosing schedule.
  • Do not get vaccinated on an empty stomach; have a proper meal before visiting the vaccination site.
  • You may be observed at the vaccination center to monitor for any immediate allergic reactions or side effects.
  • Do not interchange vaccines; the second dose must be the same COVID-19 vaccine as the first dose.
  • A minimum interval of 14 days should be maintained between the administration of any other vaccine.
  • If the benefits of vaccination outweigh the potential unknown risks of vaccine coadministration, COVID-19 and other vaccines may be administered within a shorter period (e.g., tetanus vaccine, rabies vaccine, etc.).
  • Defer vaccination for 14 days after symptom resolution if you have a confirmed or suspected COVID-19 infection.
  • Get vaccinated even if you have recovered from a COVID-19 infection in the past, as this will help develop a stronger immune response.
  • Continue to follow other preventive measures, such as social distancing, wearing masks, and hand-washing, even after getting vaccinated.

Other Combinations

Frequently asked questions

COVID-19, or Coronavirus Disease 2019, is a highly infectious illness caused by the SARS-CoV-2 virus, which primarily affects the lungs. Symptoms include breathing difficulties, fever, and cough.
Emergency Use Authorization (EUA) is a regulatory declaration that allows certain vaccines, medicines, or devices to be used during public health emergencies, such as the COVID-19 outbreak, even if they have not received full approval. It balances the benefits and risks while ensuring ongoing safety assessments.
Yes, you can still receive the vaccine without pre-registration. Visit your nearest Government health care worker for guidance on the nearest COVID-19 Vaccination Centre (CVC) and the available vaccination days. Bring your mobile phone and identification document; CVC staff will assist you with on-the-spot registration.
You can register for vaccination through the Co-WIN portal by providing basic information and photo identification details. One mobile number can register up to four individuals, but each person must have their own identification document.
Individuals with a history of severe allergic reactions to any COVID-19 vaccine or related injectable therapies should not receive this vaccine. Pregnant and lactating women have not been included in clinical trials, so they should consult their doctor before vaccination.
According to the Government of India guidelines, COVID-19 frontline workers are prioritized for vaccination, while their family members will be vaccinated based on age-specific prioritization.
Inform your doctor about any regular medications, allergies, fever, bleeding disorders, immunocompromised status, or if you are on medications affecting your immune system. Discuss any prior COVID-19 vaccinations and consult your doctor if you are pregnant or breastfeeding.
The following five vaccines have been granted emergency use authorization by the Drug Controller General of India: Covishield, Covaxin, Sputnik V, Moderna, and Johnson & Johnson’s single-dose vaccine.
COVID-19 vaccine trials for children are ongoing, and there is currently insufficient evidence to recommend its use in this population due to higher morbidity and mortality rates in older individuals, particularly those over 50. Thus, it is advised not to vaccinate children until more data is available.
The Whole Virion, Inactivated Corona Virus vaccine is administered in two doses, with the second dose given 28 days after the first. Studies are also exploring a proposed booster dose six months after the second dose, but this protocol is still under evaluation.
Yes, the Whole Virion, Inactivated Corona Virus vaccine has undergone the necessary clinical trials prior to receiving Emergency Use Authorization (EUA).
Yes, individuals who have had a prior COVID-19 infection should still receive the vaccine unless advised otherwise by their healthcare provider. The vaccine serves as a booster to enhance the immune response, and reinfections can occur, making vaccination important.
There has been no comparative study between Covishield and the Whole Virion, Inactivated Corona Virus vaccine, so it is not possible to determine which is better. Both vaccines are effective in preventing COVID-19, especially in vulnerable populations such as the elderly or those with comorbidities.
Common mild side effects may include injection site reactions (pain, swelling, redness, itching), headache, fever, malaise, nausea, vomiting, and rashes. These effects are usually temporary. If they persist, consult your doctor. No serious side effects have been reported.
The vaccine must be stored and transported at temperatures between 2°C and 8°C. A cold chain is maintained through approximately 29,000 cold chain points across India.
Yes, the vaccine is expected to provide reasonable protection against newer strains of the COVID-19 virus. Vaccination prompts the body to produce multiple types of antibodies, which can effectively combat the virus, and current data suggests that mutations are unlikely to render the vaccine ineffective.
Yes, the vaccine is safe and effective for adults with comorbidities such as hypertension, diabetes, chronic kidney disease, heart disease, and lipid disorders. It is particularly beneficial for those with such conditions, but consult your doctor if you have specific concerns.
It typically takes 2-3 weeks after completing the vaccination schedule (after the second dose) to develop an adequate immune response.
;

Flat Rs 100 on first app order   |    Use Code:  APP100   | 

Flat Rs 100 on first app order

USE CODE: APP100

PlatinumRx

Download Now

AppleIconPlayStoreIcon